Total Payments
$1,765
2024 Payments
$59.32
Companies
26
Transactions
107
Medicare Patients
4,494
Medicare Billing
$472,133
Payment Breakdown by Category
Food & Beverage$1,765 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,765 | 107 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $405.03 | 30 | $0 (2023) |
| Genentech USA, Inc. | $154.41 | 9 | $0 (2019) |
| ABBVIE INC. | $151.81 | 10 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $142.33 | 5 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $138.66 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $128.39 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $115.60 | 7 | $0 (2020) |
| Allergan, Inc. | $104.03 | 7 | $0 (2020) |
| Insmed, Inc. | $76.17 | 4 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $56.20 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.32 | 3 | CSL Behring ($23.64) |
| 2023 | $288.73 | 18 | GlaxoSmithKline, LLC. ($142.47) |
| 2022 | $346.84 | 18 | GlaxoSmithKline, LLC. ($125.09) |
| 2021 | $204.38 | 15 | AbbVie Inc. ($102.85) |
| 2020 | $148.96 | 9 | Allergan, Inc. ($52.37) |
| 2019 | $273.37 | 14 | JAZZ PHARMACEUTICALS INC. ($100.52) |
| 2018 | $166.56 | 11 | Genentech USA, Inc. ($53.30) |
| 2017 | $277.03 | 19 | Genentech USA, Inc. ($68.18) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Immunology | ||||||
| 02/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Respiratory | ||||||
| 12/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Respiratory | ||||||
| 10/19/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Respiratory | ||||||
| 09/28/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Respiratory | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: NEUROLOGY | ||||||
| 06/09/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Respiratory | ||||||
| 06/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: RESPIRATORY | ||||||
| 03/24/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Respiratory | ||||||
| 03/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: RESPIRATORY | ||||||
| 03/03/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Respiratory | ||||||
| 02/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROLOGY | ||||||
| 01/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Cardiology | ||||||
| 10/26/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,174 | 1,358 | $292,210 | $114,793 |
| 2022 | 11 | 1,104 | 1,324 | $283,357 | $111,620 |
| 2021 | 15 | 1,130 | 1,411 | $306,236 | $128,290 |
| 2020 | 12 | 1,086 | 1,370 | $272,841 | $117,431 |
Total Patients
4,494
Total Services
5,463
Medicare Billing
$472,133
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 227 | $47,216 | $20,417 | 43.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 128 | 212 | $34,132 | $18,766 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 276 | $40,296 | $16,557 | 41.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 57 | 86 | $35,088 | $13,676 | 39.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 99 | 100 | $30,300 | $12,911 | 42.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 154 | 154 | $45,430 | $12,278 | 27.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 128 | $14,720 | $7,561 | 51.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 71 | 73 | $24,355 | $6,559 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,579 | $3,386 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,554 | $1,761 | 38.7% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 32 | 35 | $2,380 | $555.07 | 23.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 13 | 13 | $4,160 | $366.85 | 8.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 341 | 369 | $53,874 | $22,294 | 41.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 69 | 122 | $49,776 | $19,848 | 39.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 115 | 202 | $32,522 | $14,883 | 45.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 96 | 96 | $29,088 | $13,903 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 135 | $28,080 | $11,391 | 40.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 112 | 112 | $33,040 | $9,297 | 28.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 68 | 72 | $22,896 | $6,723 | 29.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 126 | $14,490 | $6,600 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $14,214 | $4,606 | 32.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 16 | 21 | $3,927 | $1,728 | 44.0% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2022 | 23 | 23 | $1,450 | $347.59 | 24.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 84 | 170 | $69,360 | $30,478 | 43.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 133 | 257 | $41,377 | $20,573 | 49.7% |
About Dr. Michael Eckles, MD
Dr. Michael Eckles, MD is a Sleep Medicine healthcare provider based in Fayetteville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548298466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Eckles, MD has received a total of $1,765 in payments from pharmaceutical and medical device companies, with $59.32 received in 2024. These payments were reported across 107 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,765).
As a Medicare-enrolled provider, Eckles has provided services to 4,494 Medicare beneficiaries, totaling 5,463 services with total Medicare billing of $472,133. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Fayetteville, AR
- Active Since 06/29/2006
- Last Updated 12/27/2021
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1548298466
Products in Payments
- TRELEGY ELLIPTA (Drug) $262.08
- AVYCAZ (Drug) $255.84
- Esbriet (Biological) $121.48
- XOLAIR (Biological) $115.60
- SUNOSI (Drug) $100.52
- Arikayce (Drug) $76.17
- SYMBICORT (Drug) $71.49
- UPTRAVI (Drug) $56.20
- ANORO (Drug) $51.34
- BREO (Drug) $46.74
- FASENRA (Biological) $43.85
- ACTHAR (Biological) $41.41
- XYWAV (Drug) $38.14
- Kcentra (Biological) $35.64
- DUPIXENT (Biological) $32.58
- Trilogy 200 (Device) $30.78
- OFEV (Drug) $25.28
- NUCALA (Biological) $24.21
- XIFAXAN (Drug) $22.07
- Xolair (Biological) $21.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.